Cargando…
Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Although progress has been made in diagnosis and treatment, morbidity and mortality continue to rise. Chronic liver disease and liver cirrhosis are still the most important risk factors for liver cancer. Although...
Autores principales: | Song, Jianning, Zhou, Hongzhong, Gu, Dayong, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790246/ https://www.ncbi.nlm.nih.gov/pubmed/35096588 http://dx.doi.org/10.3389/fonc.2021.790358 |
Ejemplares similares
-
Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022) -
Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023) -
Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023) -
Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis
por: Wang, Chunling, et al.
Publicado: (2022) -
Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)